The relevance of c-myc to the physiology of the human ovary

References

• Blackwood E. M., Eisenman R. N. Max: a helix-loop-helix zipper protein that forms a sequence specific DNA-binding complex with Myc. Science 1991; 251: 1211–17
   PubMed Web of Science ®Google Scholar
• Eilers J. K., Schirm S., Bishop J. M. The Myc protein activates transcription of the alpha-prothymosin gene. EMBOJ. 1991; 10: 133–41
   PubMed Web of Science ®Google Scholar
• Buttyan R., Zakeri Z., Lockshin R., Wolgemuth D. Cascade induction ofc-fos, c-myc and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol. Endocrinol. 1988; 2: 650–7
   PubMed Web of Science ®Google Scholar
• Kyprianou N., English H. F., Davidson N. E., Isaacs J. T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 1991; 51: 162–6
   PubMed Web of Science ®Google Scholar
• Quarmby V., Beekman W., Wilson E., French F. Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate. Mol. Endocrinol. 1987; 1: 865–74
   PubMedGoogle Scholar
• Goyette M., Petropoulos C.J., Shank P. R., Fausto N. Regulated transcription of c-Ki-nu and c-myc during compensatory growth of rat liver. Mol. Cell. Biol. 1984; 4: 1493–8
   PubMed Web of Science ®Google Scholar
• Makino R., Hayashi K., Sugimura T. C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature (London) 1984; 310: 697–8
   PubMed Web of Science ®Google Scholar
• Slamon D. J., deKernion J. B., Verma I. M., Cline M. J. Expression of cellular proto-oncogenes in human malignancies. Science 1984; 224: 256–62
   PubMed Web of Science ®Google Scholar
• Yasue H., Takeda A., Ishibashi M. Amplification of the c-myc gene and the elevation of its transcript in human ovarian cell lines. Cell Struct. Funct. 1987; 12: 121–5
   PubMed Web of Science ®Google Scholar
• Delidow B. C., Lynch J. P., White B. A., Peluso J. J. Regulation ofproto-oncogene expression and deoxyribonucleic acid synthesis in granulosa cells of perfused immature rat ovaries. Biol. Reprod. 1992; 47: 428–35
   Google Scholar
• Fraser H. M., Lunn S. F., Cowen G. M., Illingworth P. j. Induced luteal regression in the primate: evidence for apoptosis and changes in c-myc protein. J. Endocrinol. 1995; 147: 131–7
   Google Scholar
• Delidow B.C., White B. A., Peluso J. J. Gonadotropin induction ofc-fos and c-myc expression and deoxyribonucleic acid synthesis in rat granulosa cells. Endocrinology 1990; 126: 2302–6
   Google Scholar
• Clement P. B. Histology of the ovary. Am. J. Surg. Pathol. 1987; 11: 277–303
   PubMed Web of Science ®Google Scholar
• Chikazawa K., Araki S., Tamada T. Morphological and endocrinological studies on follicular development during the human menstrual cycle. J. Clin. Endocrinol. Metab. 1986; 62: 305–13
   PubMedGoogle Scholar
• Gibson A. W., Cheng T., Johnston R. N. Apoptosis induced by c-myc overexpression is dependent on growth conditions. Exp. Cell Res. 1995; 218: 351–8
   Google Scholar
• Heikkila R., Schwab G., Wickstromm E., Loke S. L., Pluznik D. H., Watt R., Neckers L. M. Ac-myc antisense oligodeoxynucleotide inhibits entry into S-phase but not progress Go to G1. Nature (London) 1987; 328: 445–9
   PubMed Web of Science ®Google Scholar
• Yokoyama K., Imamoto F. Transcriptional control of the endogenous MYC proto-oncogene by antisense RNA. Proc. Natl. Acad. Sci. USA 1987; 84: 7363–7
   PubMed Web of Science ®Google Scholar
• Johnson A. L., Li Z., Tilly J. L. Expression of c-myc and bcl-2 mRNA during ovarian follicle development. Presented at the 26th Annual Meeting of the Society for the Study of Reproduction Fort Collins, USA, August, 1993, 152, abstr.
   Google Scholar
• Czerwiec F. S., Melner M. H., Puett D. Transiently elevated levels ofc-fos, c-myc oncogene messenger ribonucleic acid in cultured murine Leydig tumor cells after addition of human chorionic gonadotropin. Mot. Endocrinol. 1989; 3: 105–9
   Google Scholar
• Lin T., Blaisdell K., Barbour K. W., Thompson E. A. Transient activation of c-myc proto-oncogene expression in Leydig cells by human chorionic gonadotropin. Biochem. Biophys. Res. Commun. 1988; 157: 121–6
   Google Scholar
• Coughlin S. R., Lee W. M., Williams P. W., Giels G. M., Williams L. T. C-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF. Cell 1985; 43: 243–51
   PubMed Web of Science ®Google Scholar
• Shi Y., Glynn J. M., Guilbert L. J., Cotter T. G., Bisonette R. P., Green D. R. Role of c-myc in activation induced apoptotic cell death in T-cell hybridomas. Science 1992; 257: 212–14
   PubMed Web of Science ®Google Scholar
• Hockenbery D., Nunez G., Milliman C., Schreiber R. D., Krosmeyer S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 1990; 348: 334–6
   PubMed Web of Science ®Google Scholar
• Tilly J. L., Tilly K. I., Kenton M. L., Johnson A. L. Expression of members of the Bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-xiong messenger ribonucleic acid level. Endocrinology 1995; 136: 232–41
   PubMed Web of Science ®Google Scholar
• Copolla J. A., Cole M. D. Constitutive c-myc expression blocks mouse erythro-leukemia cell differentiation but not commitment. Nature (London) 1986; 320: 760–3
   PubMedGoogle Scholar
• Falcone G., Tao F., Alema S. Distinctive effect of the viral oncogenes myc, erb, fps and src on the differentiation programme of the quail myogenic cells. Proc. Natl. Acad. Sci. USA 1985; 82: 426–30
   PubMed Web of Science ®Google Scholar